Jump to content

MEDA

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Tillbury (talk | contribs) at 03:21, 7 April 2009 (→‎External links). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

MEDA
Names
IUPAC name
1-(8-methoxy-2,3-dihydro-1,4-benzodioxin-6-yl)propan-2-amine
Identifiers
3D model (JSmol)
  • CC(N)Cc1cc(OC)c2OCCOc2c1
Properties
C12H17NO3
Molar mass 223.268 g/mol
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).

MEDA, or 3-methoxy-4,5-ethylenedioxyamphetamine, is a lesser-known psychedelic drug. MEDA was first synthesized by Alexander Shulgin. In his book PiHKAL (Phenethylamines i Have Known And Loved), the minimum dosage is listed as 200mg, and the duration unknown. MEDA produces few to no effects. Very little data exists about the pharmacological properties, metabolism, and toxicity of MEDA.

See also


Template:PiHKAL